» Articles » PMID: 23249733

FUS Binds the CTD of RNA Polymerase II and Regulates Its Phosphorylation at Ser2

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2012 Dec 20
PMID 23249733
Citations 137
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in the RNA-binding protein FUS (fused in sarcoma)/TLS have been shown to cause the neurodegenerative disease amyotrophic lateral sclerosis (ALS), but the normal role of FUS is incompletely understood. We found that FUS binds the C-terminal domain (CTD) of RNA polymerase II (RNAP2) and prevents inappropriate hyperphosphorylation of Ser2 in the RNAP2 CTD at thousands of human genes. The loss of FUS leads to RNAP2 accumulation at the transcription start site and a shift in mRNA isoform expression toward early polyadenylation sites. Thus, in addition to its role in alternative RNA splicing, FUS has a general function in orchestrating CTD phosphorylation during RNAP2 transcription.

Citing Articles

Navigating a complex dance: the interplay between RNA-binding proteins and T cells in oral epithelial plasticity.

Vijayakumar A, Vasudevan S, John S, Ozbun M, Bartee E, Palanisamy V Immunometabolism (Cobham). 2025; 7(1):e00054.

PMID: 39816132 PMC: 11731067. DOI: 10.1097/IN9.0000000000000054.


FUS-Mediated Inhibition of Myogenesis Elicited by Suppressing TNNT1 Production.

Ji E, Pandey P, Martindale J, Yang X, Yang J, Tsitsipatis D Mol Cell Biol. 2024; 44(9):391-409.

PMID: 39133076 PMC: 11376412. DOI: 10.1080/10985549.2024.2383296.


Liquid-liquid phase separation in diseases.

Zhang X, Yuan L, Zhang W, Zhang Y, Wu Q, Li C MedComm (2020). 2024; 5(7):e640.

PMID: 39006762 PMC: 11245632. DOI: 10.1002/mco2.640.


Modulation of diverse biological processes by CPSF, the master regulator of mRNA 3' ends.

Liu L, Manley J RNA. 2024; 30(9):1122-1140.

PMID: 38986572 PMC: 11331416. DOI: 10.1261/rna.080108.124.


Endogenous EWSR1 Exists in Two Visual Modalities That Reflect Its Associations with Nucleic Acids and Concentration at Sites of Active Transcription.

Sundara Rajan S, Ebegboni V, Pichling P, Ludwig K, Jones T, Chari R Mol Cell Biol. 2024; 44(3):103-122.

PMID: 38506112 PMC: 10986767. DOI: 10.1080/10985549.2024.2315425.


References
1.
Hoell J, Larsson E, Runge S, Nusbaum J, Duggimpudi S, Farazi T . RNA targets of wild-type and mutant FET family proteins. Nat Struct Mol Biol. 2011; 18(12):1428-31. PMC: 3230689. DOI: 10.1038/nsmb.2163. View

2.
Kim H, Erickson B, Luo W, Seward D, Graber J, Pollock D . Gene-specific RNA polymerase II phosphorylation and the CTD code. Nat Struct Mol Biol. 2010; 17(10):1279-86. PMC: 3048030. DOI: 10.1038/nsmb.1913. View

3.
Yamazaki T, Chen S, Yu Y, Yan B, Haertlein T, Carrasco M . FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep. 2012; 2(4):799-806. PMC: 3483417. DOI: 10.1016/j.celrep.2012.08.025. View

4.
Kwiatkowski Jr T, Bosco D, Leclerc A, Tamrazian E, Vanderburg C, Russ C . Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science. 2009; 323(5918):1205-8. DOI: 10.1126/science.1166066. View

5.
Wang X, Arai S, Song X, Reichart D, Du K, Pascual G . Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature. 2008; 454(7200):126-30. PMC: 2823488. DOI: 10.1038/nature06992. View